- Phone: (585) 276-6123
- Office: HWH 2W322
- Email: Meghan Underhill
Meghan Underhill, PhD, APRN, AOCNS
- Assistant Professor
- Nurse Practitioner, Wilmot Cancer Institute Hereditary Cancer Program
Bio
Meghan Underhill-Blazey is an assistant professor at the University of Rochester School of Nursing, a member of Cancer Control and Prevention at the Wilmot Cancer Institute, and a nurse practitioner at the Wilmot Cancer Institute.
Underhill-Blazey has dedicated her career to understanding the experiences of and improving care for individuals and families living with inherited cancer risk. As an active nurse practitioner within the Hereditary Cancer Program, her program of research focuses on building and implementing clinical innovations that transform the focus of cancer genetics from an illness model to a wellness focused model that directly responds to the needs of individuals and families. She has widely disseminated research findings both through publications and presentations and has served as the nurse scientist on multidisciplinary teams which has had national and international impact. She has worked to share her research expertise with others and has provided long-lasting successful research mentorship to multiple pre and postdoctoral nursing trainees.
In addition to clinical practice, research, and mentorship, Underhill-Blazey has served in multiple capacities as an oncology nursing science leader both locally and nationally within the Oncology Nursing Society and the American Academy of Nursing.
Current Focus
My current focus is building interventions to support cancer genetics clinical care and the patients and families impacted by cancer genetics. I am leading a study entitled FRAME: Familial cancer Risk Assessment and Mindfulness Education to support individuals living with inherited pancreatic cancer risk. Additionally, I am leading a study to evaluate the impact of EHR-initiated intervention to promote referral and completion of cancer genetic testing in the context of pancreatic cancer. I also am leading work to understand the impact of telemedicine on cancer genetic care at the University of Rochester Medical Center. I serve as co-investigator on a number of different externally-funded projects in cancer care.
National Cancer Institute
6/2022 - 5/2026
Role: Co-Investigator
PI: Ricker, Bickmore, Braun